GUEST BLOG: First Steps to Starting an Exercise Program

Joggingby Carol Michaels

Exercise may be the furthest thing from your mind after a cancer diagnosis. Even if you have never been active, exercise can become one of your favorite activities. Ask your doctor before you start to exercise because each person is unique and heals differently. With more medical professionals recommending exercise to their patients, it is imperative for cancer survivors to learn how to exercise safely. A good exercise program will help to reduce the side effects of surgery and treatments. These side effects can include fatigue, neuropathy, decreased range of motion, weakness, lymphedema, and a significant emotional toll. Once you start to exercise and have less pain, stiffness and more energy, you will be motivated to continue.

Exercise may reduce the chance of recurrence, and it is therefore more important than ever to add exercise to your recovery plan. For those who have been active prior to their diagnosis, this is great news. A good exercise program will help you to get back to the activities that you enjoy. For the cancer survivors who have been inactive, it is never too late to start an exercise program. Work with an experienced cancer exercise specialist in your area or purchase cancer exercise books and DVD’s. This will give you the tools that you need to get started in an exercise program that is part of a healthy lifestyle.

Before You Begin
You will need to speak to your health professional before beginning an exercise program. Your particular surgery, treatments, fitness level and healing speed will guide the progression of the exercises. Your health and recovery process is always changing and it will be important to regularly monitor your blood count, muscle and joint pain, nausea, and fatigue. You may also have lingering impairments or health concerns that need to be evaluated by a physical therapist or lymphedema therapist.

You should meet with your oncologist to review the exact nature of your treatments so that you will understand the potential side effects of your treatments. This way you will be able to understand your exercise plan in relation to your unique situation. Some medications affect balance, and cardiac function, or increase the risk of dehydration. It is crucial that you understand the health issues you may encounter as a consequence of your surgery or treatment. This will include learning which muscles are affected, which lymph nodes are removed, and the cardiac and pulmonary effects of radiation and chemotherapy.

Exercise Goals
Goals should be specific and realistic. You may want to lose weight and increase your muscle mass. If flexibility is an issue, your goal may be to improve your range of motion. Other goals might be to become stronger, have a good quality of life, better mood, or to decrease the chance of recurrence.

It is helpful to have both short term and long term exercise goals. Goals should be able to be adapted to changes in work, health, and family situations. If you are new to exercise, select an activity and set an achievable goal.  Slowly add exercise to your daily activities and find something that works with your lifestyle.

Remember: Think positive and have fun!

Exercising During Chemotherapy and Radiation
It seems counterintuitive, but exercise during treatment is shown to be helpful. Physical activity during treatment can reduce common side effects such as fatigue, pain, nausea, depression or anxiety. If you are suffering from pain and nausea you should have those issues under control before beginning. Your doctor will be able to tell you how often you should exercise and how intense your program should be.

Each treatment is unique and has potentially debilitating side effects of which you should be aware.

Systemic treatments such as chemotherapy and hormonal therapy as well as targeted, biological and immunotherapies may impact your balance, cardiac function, and gastro-intestinal tract. Furthermore, they may lead to neuropathy or numbness in your extremities. Radiation can cause fatigue and increases the risk of lymphedema. It can also cause swelling and burning of the skin.

First Steps
Try to start moving as soon as possible after surgery, even if it is only walking indoors. This will help you to regain strength. If you had been inactive prior to surgery, start with short walks and increase the distance walked each time. You can also increase the frequency of the walks as you slowly increase the distance. Try to find a walking buddy and walk often. Build up strength slowly and make sure never to over do it. Just 15 minutes a day can improve your energy level and mood.

Incorporate aerobic activity into your fitness plan. Find the aerobic activity – one that increases your heart and breathing rate – that you enjoy and try to do it daily. Aerobic activity is an important component of a fitness plan and includes activities like walking, hiking, and dancing.


Carol Michaels FitnessCarol Michaels is a cancer exercise specialist and creator of the Recovery Fitness cancer exercise program. Recovery Fitness is taking place at Morristown Medical Center and several other facilities in New Jersey. Michaels also wrote “Exercise for Cancer Survivors,” a resource for cancer patients going through surgery and treatment.

New Therapeutic Approaches for Malignant Mesothelioma Using Immunotherapy to Target WT1

Slide for MARF-3-19-2014by Tao Dao, Lee M. Krug and David A. Scheinberg, Memorial Sloan Kettering Cancer Center, New York, NY

Wilms’ tumor  1 (WT1) is a protein that is present at high levels in many types of cancers (especially mesothelioma), but it is generally not found in normal cells. Therefore, we think that it is a potential target for novel therapies, and particularly immunotherapies. WT1 is typically found inside the cell, in the nucleus. Only after it is processed and moved to the surface of the cancer is it possible for the immune system to see it. We think that if we could teach the immune system to attack WT1, we could find an effective way to specifically kill mesothelioma cancer cells.

At Memorial Sloan Kettering Cancer Center, we are studying two ways to boost the immune response against WT1. The first is with a vaccine. Normally, the WT1 protein does not cause an immune response to occur. However, we found that small pieces of WT1 proteins that are just slightly different from normal WT1 protein can stimulate the immune system better. If we can teach the patient’s immune system to target WT1 using a vaccine made up of these protein pieces, then perhaps it will also learn to attack the cancer cells. In fact, when we gave the WT1 vaccine to patients along with some immune booster medicines, they developed an excellent immune response specifically to WT1. We are now studying this vaccine in a larger clinical trial to see if it is effective against the cancer. Patients who have undergone surgery for mesothelioma either get the immune boosters alone or together with the WT1 vaccine to see if it can prolong the time before the mesothelioma grows back.

We are now also studying another way to attack WT1 using antibodies. Antibodies are proteins in the body that stick to foreign substances (such as bacteria or viruses) and tag them for destruction by the immune system. In this case, however, we have engineered antibodies in a laboratory so they will recognize WT1. Thus, instead of the vaccine strategy which relies on teaching the patient’s immune system to attack WT1, these antibodies can be injected and bind directly to it. We have demonstrated that this antibody is a potent therapeutic agent against human mesothelioma in animal models. Our study was published in the Science Translational Medicine in March, 2013. (http://stm.sciencemag.org/content/5/176/176ra33.long). We are working to bring this promising new drug to clinical application in the very near future.

Acknowledgement

We greatly appreciate the grant support from the Mesothelioma Applied Research Foundation for our exciting research targeting WT1 by both vaccines and antibody therapies (TD and LMK are recipients of Meso Foundation grants).

GUEST BLOG: Krisha Deaver and Why She Needs the Symposium

Krisha and Cam Deaverby Krisha Deaver

I’ll be honest: I wasn’t sure I wanted to go to the Symposium last year. I knew I needed to go, but that’s not the same thing.

I needed to go because information is power when fighting an elusive enemy like mesothelioma.

I needed to go because fighting cancer is lonely, and I wanted to meet people who understood.

I needed to go because my husband, Cam, is everything to me—and I’ll do whatever it takes to help him beat this disease.

But all the same, I wasn’t exactly looking forward to it. In hindsight, I can recognize my hesitation for what it was: fear.

I was afraid it would be sad. I was particularly worried about a session that recognized those who had passed away during the year. I couldn’t face that — I was terrified of losing Cam. So guess what I did? I gave myself permission not to attend that session. And that was a fine approach because it was what I needed to do at the time.

I was afraid that the Symposium would be too much for me emotionally — three full days of staring into the face of meso. That fear seems laughable now. After all, hadn’t I been consumed for months doing exactly that? Through research, doctor visits, tests, and surgery, I’d been relentlessly staring down the beast.

Rather than being overwhelming, the Symposium was a tremendous relief. Admittedly, there was a lot of information and new faces and ideas to take in, but I ultimately found myself surrounded by people equally passionate about finding answers to this disease.

It was a relief to hear researchers present their findings. Even if I didn’t follow all the science, I understood enough, and I was grateful that the researchers could see my pleading eyes in the audience. I’m glad that I sat next to my husband, squeezing his hand, and helped to put a face to the need for more research.

It was a relief to attend the session for caregivers and hear from a panel that helped me feel connected. It was a relief to ask my toughest questions to that group and gain their wisdom and support.

It was a relief to approach a brilliant researcher after her presentation and ask a follow-up question specific to Cam’s recovery. I was able to pick the brains of every other doctor I could catch.

It was a relief to hear from dedicated and passionate fundraisers and learn how I can help contribute to the effort to find a cure.

As the Symposium was winding down, it was a wonderful relief to attend the closing celebration. At this annual dinner, I listened to Cam optimistically talk about his journey and perspective, and it was one of the proudest moments of my life.

In the year since the Symposium, when I feel fear creeping in, one of the things that keeps me grounded is remembering the network of support I built by attending. Even though Cam and I were part of the Meso Foundation’s online community prior to the Symposium, nothing can compare to actually meeting others who “get it.”

At this year’s Symposium, I can’t wait for a fresh infusion of information, friends, and hope. Fear doesn’t stand a chance.

GUEST BLOG: Cam Deaver and his Happy Voices

Cam Deaverby Cam Deaver

Shortly after my HIPEC surgery, I started hearing voices. Talking, laughing, sometimes crying. But mostly happy. Now I hear them every day. And I often have visions of faces, too.

I’ve never talked with anyone about this phenomenon because it doesn’t upset me. And I don’t think doctors could do anything about it anyway. Really, I don’t want it to change ever, because it has given me tremendous comfort and strength as a mesothelioma survivor.

The phenomenon began when I went to the Meso Foundation’s Symposium last year. That’s where I first heard the voices and saw the faces and felt the hugs of survivors, families, and doctors who knew what I was going through.

I had exchanged messages online with many of them before, and I had even talked to a few of them on the phone, but nothing prepared me for the experience of meeting in person at the Symposium.

I was just a couple months into my recovery at the time, and I felt like I had turned the corner. I was happy with my circumstances and thought I had an abundance of positive energy to share.

My wife and I expected the Symposium to be a somber affair—three days immersed in the gloom of illness and fear and desperation. We promised each other we’d do everything possible to spread cheer and give others a lift.

But we never had the chance. From the moment we arrived, we were caught in a wave of friendship, concern, and hope that never let go.

Don’t misunderstand—there were certainly many serious discussions and some sad moments. But more than we could have imagined, we saw encouragement beat back worry, knowledge overcome fear, gratitude conquer grief, and smiles shine brighter than tears.

Those are the voices and faces that come around every day now.

When I’m concerned about my future health, I hear Dr. Carbone’s exuberant Italian accent (and see his waves of luxuriant Italian hair!), Dr. Pingpank’s calm confidence, or Dr. Alexander’s deep concern, and I know that there are scores of doctors and researchers working to help me.

When I’m confused about test results, treatments, or what steps to take next, Mary is there offering insight, wisdom, and encouragement and keeping me grounded and focused on getting healthier.

I see Melinda, Maja, Erica, Erin, Jessica, Anna, Dana, and Beth raising money, funding research, advocating, organizing, speaking, writing, and reaching out to support me.

I see Hanne, Marina, Shelly, Don, Betty and others who have lost loved ones but continue to work ceaselessly for those of us still fighting. I see a husband and son play their hearts out in the Meso Fighters Band, just weeks after losing their wife and mother.

I see a few people who have since passed away, like Janelle. I met her only once, toward the end of her fight, but I still remember the way her eyes and smile and determination sparked hope in everyone around her.

I hear and see all the beautiful souls who will not let mesothelioma win; those who joyfully count the days, weeks, months, and years of life and love that cancer can never steal. They are quick with a message or a call when I’m having a down day. They give practical advice about dealing with cancer and share infinite strength whenever I need it.

Going into last year’s Symposium, I thought I was doing great in my battle with mesothelioma. Nonetheless, I left the conference with ten times the information, hope, and courage I had before, and the people I met there continue to bless my life in real ways every day.

I hope you can come this year. There are sessions and events that touch on all aspects of beating this disease and dealing with its impact on our lives.

Reading information online doesn’t compare to meeting in-person with people who get it because they have lived it and made it through to the other side. In the grim world of cancer, this conference is the happiest place on earth.

I want you to hear voices and see faces all year round. It’s a beautiful, amazing thing.

GUEST POST: Dr. Michele Carbone in Memory of Dr. Baris

carboneBy Michele Carbone, MD

This past week-end my friend Professor Izzettin Y Baris died in Turkey.  Dr. Baris, as I called him, was one of the most exceptional individuals I had the privilege to meet. He made a real difference in the life of his patients, and he dedicated his life to improve the conditions of the cancer villages in Cappadocia: Karain, Sarihidir and Tuzkoy. What follows are few memories of my long association with him.

Dr. Baris invited me in November of 1997 to give the Keynote lecture at the Turkish Annual Lung Cancer Meeting. He was then the President of the Society and also the Director of Pulmonary Medicine at the University of Hacettepe, in Ankara. I told him, “Sure, I will come, but will you please take me to the Cancer villages? “

Baris had discovered in the 70s an epidemic of malignant mesothelioma in these villages where over 50% of all cancer deaths were–and still are–caused by mesothelioma. The “Major” of Karain had gone to Baris’ office complaining of an epidemic of tuberculosis that was decimating his village and medicines would not help those who were sick. When Baris visited the villages — 5 hours drive South of Ankara — and the patients, he realized that those people had instead mesothelioma. Thus, Baris discovered the most incredible cancer epidemic, or better epidemic, that has ever been described in medicine. No disease kills 50% of those who are exposed, even the infamous Spanish influenza, which killed “only” up to 20% of those that were exposed. Baris linked the epidemic to exposure to erionite, a type of mineral fiber more potent than asbestos in causing mesothelioma.

Baris expected me to be a senior old Professor; instead when we met, he was confronted with an athletic, long-haired, 37 year old “kid”, and he did not quite know what to make of me. We went to his office. Baris sat behind his desk. Dr. Luciano Mutti, a mesothelioma expert from Italy, Baris’ Assistant Professor Dr. Salih Emri, Dr. Umran Dogan, a mineralogist, a US reporter, Debbie Bookchin, and myself sat in front of him. As Baris was describing his experience of working with the villagers over the years, a man in his late 40s entered the room. The man kneeled, said something, Baris touched his head, the man kissed the hand of Dr. Baris, thanked Baris and walked out. We were speechless, and I asked what was that about? “He is one of my Associate Professors, he asked permission to leave at 4:30 pm for a family emergency and I said he could go,” was Baris’s reply.

That episode tells better than anything the world in which Baris lived. He was the Professor, a famous Professor, and those around him respected him, loved him and feared him: as one of his assistant professors told me, if Professor Baris says it’s raining, it’s raining, no matter if in fact sun is shining. Well, I had left Italy to go the US, because I did not like the “Herr” Professor attitude of the Italian Academia, how could I possibly go along with someone who appeared to represent exactly what I did not like of Italian Academia?

The next day we went to Karain, Tuzkoy and Sarihidir, Baris introduced me to the villagers, we saw several patients, a woman who was dying of mesothelioma in Tuzkoy, a man in Sarihidir. The patients had horrible pain, Turkish law allowed only patients to pick up prescription for morphine, they could not delegate family members. Patients were too sick to travel to the pharmacy, hours away, and so had no effective way to control pain.  Thanks to Baris, we changed that, and convinced the Turkish Ministry of Health to modify the law so that patients could delegate family members to pick up medicines, including morphine.

Baris was very assertive, there was only one opinion, his opinion, and nobody could challenge it. I realized his Assistant Professor was right, if Baris says it rains, it rains. I could not stand that, and I argued with him about almost everything. I told him I did not buy his hypothesis that the epidemic was caused only by erionite exposure. It had to be something else in addition to erionite. He told me I was a fool.

I went back to America, assembled a team and studied the Cappadocia epidemic on my own, with the help of some locals I had met during my visit, and the “secret” help of some of Baris colleagues. In 2001, I published a paper in The Lancet in which I reported that susceptibility to mesothelioma was genetically transmitted, autosomal dominant. Before publishing the paper, as a courtesy, I sent a copy to Dr. Baris. Soon after I got an email from Baris, “I read your paper, I do not believe your data, I think your pedigrees [genealogies] are wrong, please send them to me I will double check myself.” I sent him the pedigrees. A few weeks later I got an email back from Baris: ”I checked, except for 2 minor mistakes the pedigrees are correct, therefore now I agree with you”. That was unexpected! I was totally wrong about this man, this old Professor had gone himself to the villages, spent weeks there, to check my data and now he was accepting a point of view diametrically different than his. It takes a special man to do so, a strong and, as Baris said, “honest man”, to change his mind because of the facts he is confronted with.

Soon after, I was invited again to speak at the Turkish lung cancer society, there was now a new President and Baris was retired from the University. I did not expect or plan to see Baris. The meeting was in Istanbul, and Baris was living in Ankara and was not on the speakers list. I had just started my presentation, several hundred people were in attendance, when Baris, unexpectedly, entered the room and started walking down the aisle. Dr. Baris is here! Everybody in the room stood up and turned around, the meeting organizer run up the aisle to escort Dr. Baris. I stopped talking: I have given speeches all over the world, I have never seen such an amount of respect. Baris walked down the aisle, sat straight in front of me, first row, and I resumed my talk. He had driven that morning all the way from Ankara to listen to my talk. My presentation had several slides of him, me and him at the villages, about his great work, etc. (see attached power point). He was pleased and walked out of the room as soon as I finished my speech and was surrounded by a crowd. I walked out too, and Isa Duru, the pharmacist who was born in Karain, a good friend of Dr. Baris who had travelled with him to Istanbul, and who would in subsequent years play an important role in our research in Cappadocia, came up to me and start arguing. Isa said that “there is no genetic cause of mesothelioma in Cappadocia, you are wrong. Some people have a weaker immune system and are more susceptible than others to erionite, this is why some families have more mesothelioma, but there is no genetic “defect”.  I realized we were in agreement and I was just using the wrong words. I told Isa, you are right some people are more susceptible than others, maybe because their immune system is not as strong. Baris came up to us, pointing at me said “Isa, he is a honest man”, then he looked at me and said “Isa is a honest man.  The 3 of us will work together”. And we did.

Now Baris allowed me to disagree with him, actually he seemed to enjoy it, he started studying genetics and we discussed for hours different hypotheses and possibilities. He told me he was retired, he had time available and he was going to work with me to find the mesothelioma gene to save “his” people from mesothelioma. Later he complained he was getting too old for it. Baris actually did not know the year he was born but during one of our long trips from Ankara to Cappadocia he estimated he had to be born sometimes in the late 1920s. He said I needed a younger collaborator, someone who had the energy he used to have: I told him I need another Baris, please find me someone like you and I will gladly work with him. “God lost the mold he used when he made me. He does no longer make people like me”. Laughing he told me that many times; I completely agreed, so I kept working with him.

I submitted – and won — a PO1 grant to the NCI to identify the mesothelioma gene and conduct some of the studies in Cappadocia, with Baris. Since he was retired and foreign, I had to include him in the grant as a “consultant”, and to “convince” the reviewers the collaboration was real I had to pay him. Baris had never charged a villager or a mesothelioma patients, he treated them for free, actually often gave them money to help them out and to buy medicines. So when I told him I was going to pay him he was upset. “How can I take money to help my own people? This is my own blood, these are Turkish people, how can I get paid by Americans to do my duty to my country? This is a shame!” I explained him that unless I put his time and effort on the grant and paid him, the reviewers would have never believed he actually worked on the grant with me and we would decrease the probabilities of winning the grant. “We are physicians, our duty is to help people, how can I charge to help someone who needs my help? Who are these reviewers? Don’t they have any honor or dignity?” and so on and on. Eventually we agreed that I would pay him $10,000 dollars and he would use the money to help the villagers.  And he did! He paid to pave the road that brings to one of the mesothelioma villages, to repair schools and houses, to help patients, to buy medicines, he bought books and toys for kids, etc. etc. And he told me, many times “I hope God will forgive me for taking this money from you, this is a shame, but I am using all of it to help the villagers”. In fact he spent much more than we paid him to help the villagers! And he spent many more hours working in the villages then he ever charged to the grant.

Over dinner, under the stars of Cappadocia, we discussed the destiny of those kids who were being raised in these villages full of erionite, what a horrible destiny was ahead of them.  We were in a restaurant near Sarihidir, next to the red river: they raise trout, and they will catch one in front of you and cook it. Delicious. It was Baris preferred restaurant.  One guy at the table had a cousin who worked for the Ministry of Health, we decided to ask for an appointment with the Ministry and try to convince him to build a new village free of erionite. Thanks to the “cousin” we got an appointment for the following week. I postponed my return flight to the US and a week later I was in the Ministry of Health office together with Baris and with other 40 or so people all of them asking for different favors. We were 4th in line, and we had not prepared a speech, we knew what we wanted but we were totally unprepared. As we were summoned in front of the Ministry, Baris told me, you talk, you are a foreigner Professor and if you talk maybe he will listen to you more than to me.  So Baris introduced me to the Minister – no idea what he said since he spoke in Turkish – and then he asked me to talk. I told the Ministry about the plague in the villages, about saving future generations from a horrible death from mesothelioma, and asked him to build a new village with brick and cement and move the villagers there so that they would not breathe erionite and would not get cancer (my hypothesis was that a combination of genetic predisposition and exposure to erionite caused mesothelioma, removing erionite should be sufficient to prevent mesothelioma). The Minister said only one word: Yes. He shook my hand and we were asked to leave as the next person in line had already come up to talk to the Ministry. We walked out of there thinking we had wasted our time.

When I came back a year later, Baris was all smiles, and they told me they had a surprise for me. A government blue jeep drove us to the villages, it was me, Baris, a Turkish journalist and a representative of the Ministry of Health. When we arrived in Tuzkoy the new village had been built: over 300 new homes. Today the villagers of Tuzkoy the largest of the mesothelioma villages enjoy living in the new homes, a few miles from “old” Tuzkoy but enough to protect them from erionite exposure. (See Carbone M et al., Nature Rev Cancer 2007, attached). Moreover, thanks to Dr. Murat Tuncer, then a Professor and now Rector at Hacettepe University and then Director of Cancer Control at the Turkish Ministry of Health, a clinic was built in Tuzkoy to help all villagers and especially mesothelioma patients (see attached power point – PowerPoint).

Some envious people criticized Baris and the government on Turkish National TV for having moved the village in too close proximity of “old” Tuzkoy, and so, they said, people are still exposed to erionite. Baris was disgusted, “Why people can only criticize and can never do something useful”? I told him not to worry we would have proven them wrong.  So, with approval from Dr Tuncer, I invited to Cappadocia Aubrey Miller and his team from the Environmental Protection Agency (EPA) and in April of 2008 we spent 2 weeks sampling the air in Old Tuzkoy and new Tuzkoy and in other villages, to compare air concentrations. Baris and I published the paper in 2011 (Carbone M. et al., Proc Natl Aca Sci USA, attached) showing that by moving the village air concentrations had dropped by over 1000 folds, within ranges considered “background” exposure if those were asbestos fibers in the air in the US. In short, Baris’s persistence and the courageous support of the Turkish Ministry of Health had, by building a new village, almost completely eliminated erionite exposure, probably saving thousand of future lives to mesothelioma. All those kids who are now playing in the streets of Tuzkoy will probably never know that Baris and the Turkish government saved them from a horrible death.

And what about the gene? We found it, too. But because of the difficulty in studying DNAs from Turkey, we isolated it from members of US families who experience a similar high incidence of mesothelioma. The gene, called BAP1 causes a novel cancer syndrome, with very high prevalence of mesothelioma, eye melanoma, and other cancers (Carbone et al., Nat Rev Cancer 2013). However, by the time we discovered the gene, Dr. Baris was too ill to participate in the final stages of the research.

So when a couple of hours ago, I heard that Dr Baris died, I had mixed feelings, I was sorry he died and yet I was relieved he would no longer suffer. I lost a friend, the world lost a great man and a great physician. He loved his country and his people and he honored his country in every aspect of his life. Honor and duty to his country was what motivated him and made him drive 10 hours a day back and forth to the villages even when he was in his 80s. When he introduced someone to me he would –sometimes –add: “He is an honest man”. That was the greatest compliment from Baris, and it was not an easy compliment to earn.  Dr. Baris was the most ”honest man” of us all.

Two papers co-authored with Dr. Baris:

Erionite exposure in North Dakota and Turkish villages with mesothelioma

A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes

Photographs of Dr. Baris with Dr. Carbone

Michele Carbone, M.D., Ph.D. is a Professor of Pathology and the Director of the University of Hawaii Cancer Center, a National Cancer Institute designated Consortium Cancer Center affiliated to the University of Hawaii – Manoa.

He received his MD and Ph.D. from the Medical School of Rome “La Sapienza”. He is board certified in Anatomic Pathology in both, Italy and US. He came to the US in 1986 as a recipient of a Fogarty Fellow Award and worked in the Viral Pathogenesis section at the National Institutes of Health in Bethesda MD until 1994.

He moved to the University of Chicago in 1994 and in 1997 moved to the Cancer Center of the Loyola University of Chicago where he was a Professor of Pathology and the Director of Thoracic Oncology. In June of 2006, he left Loyola to join the University of Hawaii. Dr. Carbone has published over 150 peer-reviewed papers: most of them deal with the pathogenesis of mesothelioma.

Dr. Carbone has the honorary title of Knight of Italy that he received in 2003 for his achievements in Science and Medicine.